B2B Lead Generation for Biotech and Life Sciences Companies
B2B lead generation for biotech that ends in booked sales calls, not contact lists. We find life science companies with a fresh reason to buy now, reach the people who choose a partner and book them into your calendar. You close.
No phone number required. No sales spam.
Pipeline and revenue figures are reported by our clients.
Who We Book Calls For Biotech and Life Sciences Companies
We book calls with the people who choose a partner, a tool or a service, at the life science companies you want to sell to.
Buyer Roles
Chief Scientific Officer or VP of R&D
Owns the science and picks the partners for it.
VP of Clinical Operations
Runs the trials and chooses the CROs and trial tools.
CFO or Head of Business Development
Weighs the cost, the terms and how far the money goes.
Procurement or Lab Operations Lead
Buys the tools, supplies and services the lab runs on.
Company Types
Venture-Backed Biotech Companies
Newly funded teams that need partners to move their programs forward.
Pharma and Specialty Pharma Companies
Large programs with many vendors and long contracts.
CROs and CDMOs
Service firms that also buy tools, software and partner services.
Commercial Labs and Diagnostics Companies
Labs that buy instruments, supplies and software.
Biotech Buying Windows
A buying window is a short stretch of time when a company is open to a new partner, tool or service. We watch for these signs and reach out while the window is open.
New Funding Round
Fresh money pays for the trials, tools and hires that were on hold.
Trial Phase Change
A new phase brings new sites, vendors and data needs.
New Lab or Facility
A new site needs equipment, supplies and services from day one.
New Leadership Hire
A new CSO or head of clinical operations often reviews current partners.
Licensing or Partnership Deal
A new deal adds programs that need more help.
We find these through public buying signals.
The Biotech Buying Group
Buying in biotech is rarely one person’s call. Scientists judge the fit, clinical operations runs the work, and finance and procurement approve the spend.
We map each person first, then reach each one on the channel that fits them. Reaching several people at one company is called multi-threading. If one person goes quiet, the conversation keeps going.
- Signs: Chief Scientific Officer, CFO
- Influences: VP of Clinical Operations, Procurement Lead
- Uses: Lab Manager, Research Scientist
How We Size Your Biotech Market
Before any outreach, we count your market. Not a guess, a count.
- 1We start with the life science segments you sell to, like biotech, pharma, CROs or labs.
- 2We count each company that fits, from company databases and public records like ClinicalTrials.gov.
- 3We take out your current clients, partners and open deals.
- 4We count the decision-makers we can reach at each company.
You see every number and where it came from before we start. Buying signals never shrink your market. They only decide who hears from us first.
How Our Biotech Lead Generation Works
It takes about 3 weeks from kickoff to the first qualified replies.
1Map Your Market
We agree on the segments, stages and regions you sell to, and the companies to leave out. You approve the targeting first.
2Find In-Market Companies
Public signals, like a funding round, a trial phase change or a new lab, decide who hears from us first.
3Map the Buying Group
We find each person who decides at the company, not just one contact.
4Reach Out
New sending domains warm up for at least 14 days. Cold email is our primary channel, with LinkedIn and calls added. When a signal is urgent, our SDR calls before the emails start. An optional ad warm-up can run first. Our SDRs are based in the US, the UK and Canada. Calls are recorded, and you can listen to them.
5Qualify and Book
Each call is checked against a written standard. It lands in your calendar with a brief on the company, the person and why they want to talk.
Tools We Use
Clay
Bitscale
Apollo
Ocean.io
Airscale
Findymail
LinkedIn Sales Navigator
Instantly
Smartlead
Lemlist
Outboundry
HubSpot
Pipedrive
Salesforce
Close
monday.com
n8n
Make
Zapier
Claude Code
ChatGPT
Gong
Wispr Flow
Zoom
Google Meet
Calendly
Loom
Google Workspace
Google Calendar
Notion
Confluence
Google Drive
Airtable
Google Sheets
Slack
WhatsApp
Twilio
Meta Ads
Google Ads
What the Topline Revenue Growth Program™ Includes
Topline Revenue Growth Program™
$3,500/ month
90-day program, paid monthly
Channels
- Cold email, our primary channel
- LinkedIn DMs
- LinkedIn InMail
- Cold calling
- WhatsApp and SMS, once a prospect opts in
- Optional 30-day ad warm-up (ad spend billed separately)
Includes
- Market count and exclusion list, agreed with you in writing
- In-market companies in their live buying windows
- The buying group at each company
- Messaging package, sent to you for review first
- Sending Domain Setup, Minimum 14 Day Warmup
- Each Qualified Commercial Opportunity™ (QCO) booked into your calendar with a brief
- An SDR trained on your product, your service and your selling package. Senior SDRs join as the campaign grows. Calls are recorded, and you can listen to every one. Our SDRs are based in the US, UK and Canada.
- A campaign report every Friday
- An update call every 2 weeks on your best campaigns, which segments to scale, your paid ads, and where email volume and copy drive the most results
- 10 Qualified Sales Calls Per Month, Guaranteed. For markets of 10,000+ companies.
What Counts as a Qualified Commercial Opportunity™
A Qualified Commercial Opportunity (QCO) is a qualified sales call: a scheduled conversation between you and a decision-maker of a company that matches your target market, shows a current reason to need your service, and has agreed to discuss it. It does not require a confirmed budget, purchase timeframe or commitment to buy.
For a CRO, that could be a VP of clinical operations whose company just moved a program into Phase 2 and agreed to talk about trial support.
Results Clients Have Reported
One company announced a big datacenter upgrade, so we contacted it first. The call was booked about 3 days later. The $1.3M deal closed about 3 weeks into the talks.

Who Our Biotech Lead Generation Is For
Best for B2B companies where Average Client Value is $15K+.
For
- Biotech companies selling services, data or partnerships to other life science companies
- CROs, CDMOs, and life science tools and software companies
- Teams that can run a sales call and close
- Companies selling into the United States, the UK, Canada, Australia or the EU (outside Germany, Austria and Switzerland)
Not For
- Pre-revenue companies
- Products sold to patients or consumers
- Anyone who wants pay-per-lead, commission-only terms or guaranteed closed deals
B2B Lead Generation for Biotech FAQs
How much does B2B lead generation for biotech cost?
Lead generation can be priced per lead, per meeting or as a monthly program. Tactera Digital uses a monthly program: the Topline Revenue Growth Program™ costs $3,500 a month for a 90-day program, paid monthly. It renews after the 90 days unless you give notice 5 days before the end. There are no per-lead or per-meeting fees.
How long until the first qualified sales calls?
The first qualified replies usually arrive at about the end of week 3. Weeks 1 and 2 go to targeting, messaging and the exclusion list, while new sending domains warm up for at least 14 days. Calls follow from the first replies.
What does this service include, and what does the client own?
It includes the market count, in-market company research, buying group mapping, the messaging package, sending domains, outreach by cold email, LinkedIn and calls, and qualified booking into your calendar. On the paid program, you own the work: the lists, research, copy and records. During the Pilot Program, Tactera Digital keeps it.
How do you find the right decision-makers at a biotech company?
We map the buying group at each company: the science lead, the clinical or lab operations lead, and the finance and procurement people who approve the spend. Then we reach each one on the channel that fits them, so the talk never rests on one contact.
Can you target biotech companies by funding stage or trial phase?
Yes. We can target by funding stage, trial phase, therapy area, company size and region. We count that market first, from company databases and public sources like ClinicalTrials.gov, so you know how many companies fit before outreach starts.
How is this different from buying a biotech contact database?
A database gives you names. We find the companies with a current reason to buy, reach their buying group by email, LinkedIn and phone, and book qualified sales calls into your calendar. You get calls, not a list to work yourself.
Who is this not a fit for?
It is not a fit for pre-revenue companies, products sold to patients or consumers, or anyone who wants pay-per-lead, commission-only terms or guaranteed closed deals. It fits biotech, CRO, CDMO and life science tools companies that sell to other businesses and have a team that can run a sales call and close.
About Tactera Digital
Tactera Digital is a Topline Revenue Growth Partner for high-value B2B companies. We find companies already in-market for what our clients sell and turn them into qualified sales pipeline, using signal-based outbound across LinkedIn, email and cold calling, with decision-makers booked directly into the client’s calendar. In the past 2 years, we have generated $110M+ in sales pipeline, $50M+ in closed revenue and 4,000+ commercial opportunities for our clients.
Founded and run by Bryan Phocum.
See If Biotech Lead Generation Fits Your Market
Tell us what you sell and who buys it. We check your market and tell you whether we’re a fit. No phone number required. No sales spam.
